Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 51 to 100 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
51\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 4 (neurod4). [source:swissprot;acc:q9hd90]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
779.167\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
52\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain helicase dna binding protein 5. [source:refseq;acc:nm\_015557]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
53\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinase 2-associated protein 1 (cdk2-associated protein 1) (putative oral cancer suppressor) (deleted in oral cancer- 1) (doc-1). [source:swissprot;acc:o14519]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
54\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deltex 2. [source:refseq;acc:nm\_020892]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1618.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2651.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.63814\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
55\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deltex homolog 1; hdx-1. [source:refseq;acc:nm\_004416]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1629.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2662.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.63399\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
56\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-lak cell-originated protein kinase; spermatogenesis-related protein kinase; pdz-binding kinase; pbk; mapkk-like protein kinase; serine/threonine protein kinase. [source:refseq;acc:nm\_018492]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1631.67\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2664.55\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.63302\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
57\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 3; sam68-like phosphotyrosine protein, t-star. [source:refseq;acc:nm\_006558]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 1; gap-associated tyrosine phosphoprotein p62 (sam68). [source:refseq;acc:nm\_006559]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain-containing, rna-binding, signal transduction-associated protein 2; sam68-like mammalian protein 1. [source:refseq;acc:nm\_152688]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
60\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
61\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, brain form (ec 2.4.1.1). [source:swissprot;acc:p11216]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
62\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, liver form (ec 2.4.1.1). [source:swissprot;acc:p06737]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
63\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin xv (unconventional myosin-15). [source:swissprot;acc:q9ukn7]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
64\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
65\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuralized-like. [source:refseq;acc:nm\_004210]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1657.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2690.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.6229\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
66\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1991.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3221.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.61795\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
67\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
68\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
69\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
70\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
71\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, alpha isoform (pp2a, subunit b, b-alpha isoform) (pp2a, subunit b, b55-alpha isoform) (pp2a, subunit b, pr55-alpha isoform) (pp2a, subunit b, r2-alpha isoform). [source:swissprot;acc:q00007]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4556.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2945.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.54716\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
72\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uncharacterized hematopoietic stem/progenitor cells protein mds026. [source:sptrembl;acc:q9nz48]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4556.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2945.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.54715\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
73\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, beta isoform (pp2a, subunit b, b-beta isoform) (pp2a, subunit b, b55- beta isoform) (pp2a, subunit b, pr55-beta isoform) (pp2a, subunit b, r2-beta isoform). [source:swissprot;acc:q00005]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4556.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2945.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.54711\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
74\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, gamma isoform (pp2a, subunit b, b-gamma isoform) (pp2a, subunit b, b55-gamma isoform) (pp2a, subunit b, pr55-gamma isoform) (pp2a, subunit b, r2-gamma isoform) (imypno1). [source:swissprot;acc:q9y2t4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4556.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2945.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.54694\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
75\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 18 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-18 kda) (ci-18 kda) (complex i- aqdq) (ci-aqdq). [source:swissprot;acc:o43181]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1920.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2907.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.5137\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
76\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, beta isoform (pp2a, subunit a, pr65-beta isoform) (pp2a, subunit a, r1-beta isoform). [source:swissprot;acc:p30154]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4599.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3058.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.50373\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
77\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, alpha isoform (pp2a, subunit a, pr65-alpha isoform) (pp2a, subunit a, r1-alpha isoform) (medium tumor antigen-associated 61 kda protein). [source:swissprot;acc:p30153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4612.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3093.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.49095\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
78\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-3 (activating transcription factor 3). [source:swissprot;acc:p18847]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4800.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7132.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.48573\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
79\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-126 (protein hspc155). [source:swissprot;acc:q9y3c8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3074.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4567.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.48558\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
80\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolysin tia-1 (rna-binding protein tia-1) (p40-tia-1) [contains: p15-tia-1]. [source:swissprot;acc:p31483]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4133.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5945.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.43834\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
81\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolysin tiar (tia-1 related protein). [source:swissprot;acc:q01085]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4136.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5943.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.43691\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
82\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d1 (snrnp core protein d1) (sm-d1) (sm-d autoantigen). [source:swissprot;acc:p13641]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4172.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5954.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42694\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
83\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene protein c-fos (cellular oncogene fos) (g0/g1 switch regulatory protein 7). [source:swissprot;acc:p01100]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4932.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7033.29\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.42597\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
84\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
jun dimerization protein. [source:refseq;acc:nm\_130469]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
85\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4941.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7037.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42395\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
86\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein fosb (g0/g1 switch regulatory protein 3). [source:swissprot;acc:p53539]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4942.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7037.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42384\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
87\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 1 (fra-1). [source:swissprot;acc:p15407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4944.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7038.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42347\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
88\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 2; voltage-sensitive potassium channel; voltage-gated potassium channel kv4.2. [source:refseq;acc:nm\_012281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2411.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1695.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42259\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
89\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cystathionine gamma-lyase (ec 4.4.1.1) (gamma-cystathionase). [source:swissprot;acc:p32929]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2414.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1698.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.4217\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
90\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 3 isoform 1; sha1-related potassium channel kv4.3; voltage-gated k+ channel; potassium ionic channel kv4.3; voltage-gated potassium channel kv4.3. [source:refseq;acc:nm\_004980]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2414.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1698.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.4215\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
91\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 1; shal-type potassium channel; voltage-gated potassium channel kv4.1. [source:refseq;acc:nm\_004979]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2416.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1700.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42082\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
92\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj820b18.1 (similar to nuclear cap binding protein) (fragment). [source:sptrembl;acc:q8wwk2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4117.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5801.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.40882\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
93\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
formin binding protein 3; fas-ligand associated factor 1; huntingtin-interacting protein a; ny-ren-6 antigen. [source:refseq;acc:nm\_017892]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4245.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5942.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.39977\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
94\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin-interacting protein hypa/fbp11 (fragment). [source:sptrembl;acc:o75404]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4247.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5941.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.39879\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
95\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
son protein (son3) (negative regulatory element-binding protein) (nre- binding protein) (dbp-5) (bax antagonist selected in saccharomyces 1) (bass1) (protein c21orf50). [source:swissprot;acc:p18583]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2397.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3343.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.39481\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
96\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lag1 longevity assurance homolog 2 isoform 1; l3 pigment; tumor metastasis-suppressor. [source:refseq;acc:nm\_022075]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4110.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5694.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.3856\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
97\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
amyloid beta a4 precursor protein-binding family a member 1 (neuron- specific x11 protein) (neuronal munc18-1-interacting protein 1) (mint-1) (adapter protein x11alpha). [source:swissprot;acc:q02410]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2820.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3897.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.3817\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
98\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
presenilin 2 (ps-2) (stm-2) (e5-1) (ad3lp) (ad5). [source:swissprot;acc:p49810]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
2353.63\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3225.65\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.3705\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
99\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
s-phase kinase-associated protein 1a (cyclin a/cdk2-associated protein p19) (p19a) (p19skp1) (rna polymerase ii elongation factor-like protein) (organ of corti protein 2) (ocp-ii protein) (ocp-2) (transcription elongation factor b) (siii). [source:swissprot;acc:p34991]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
f-box protein fbw7 isoform 2; archipelago, drosophila, homolog of; f-box protein fbw7; f-box protein sel-10; homolog of c elegans sel-10. [source:refseq;acc:nm\_018315]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/